| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adjuvant Treatment of Residual Disease Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle Invasive Bladder Cancer
|
Krebs, Markus
|
|
|
6 |
4 |
p. 525-535
|
article
|
| 2 |
Bladder Cancer Incidence and Survival in the United States and Texas Non-Latino Whites and Latinos
|
Wu, Shenghui
|
|
|
6 |
4 |
p. 497-506
|
article
|
| 3 |
Challenging Cases in Urothelial Cancer: Case 181
|
Soloway, Mark S.
|
|
|
6 |
4 |
p. 549-551
|
article
|
| 4 |
Clinical Trials Corner Issue 6(4)
|
Agarwal, Piyush K.
|
|
|
6 |
4 |
p. 553-556
|
article
|
| 5 |
Deciding When to Omit Repeat Transurethral Resection of Superficial Bladder Cancer: Do Photodynamic Diagnostics help?
|
Sailer, Eva
|
|
|
6 |
4 |
p. 489-496
|
article
|
| 6 |
Diagnosis and Management of Checkpoint Inhibitor Side Effects in Patients with Bladder Cancer: the Urologist’s Perspective
|
Shore, Neal
|
|
|
6 |
4 |
p. 425-433
|
article
|
| 7 |
Etiology of Treatment Delays in Patients Receiving Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
|
El-Arabi, Ahmad M.
|
|
|
6 |
4 |
p. 435-444
|
article
|
| 8 |
Festschrift in Honor of Professor Margaret Anne Knowles
|
Zwarthoff, Ellen
|
|
|
6 |
4 |
p. 537-548
|
article
|
| 9 |
FGFR3 – a Central Player in Bladder Cancer Pathogenesis?
|
Knowles, Margaret A.
|
|
|
6 |
4 |
p. 403-423
|
article
|
| 10 |
Hyperthermia Improves Solubility of Intravesical Chemotherapeutic Agents
|
Grimberg, Dominic C.
|
|
|
6 |
4 |
p. 461-470
|
article
|
| 11 |
Identification of Sex Differences in Tumor-Specific T Cell Infiltration in Bladder Tumor-Bearing Mice Treated with BCG Immunotherapy
|
Rousseau, Matthieu
|
|
|
6 |
4 |
p. 507-524
|
article
|
| 12 |
Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer1
|
|
|
|
6 |
4 |
p. 559
|
article
|
| 13 |
Outcomes of Trimodal Therapy for cT2-3 Urothelial Carcinoma in a Racially Diverse Population: A Single Institution Experience in the Bronx1
|
Gottlieb, Josh
|
|
|
6 |
4 |
p. 453-460
|
article
|
| 14 |
5α-Reductase Inhibitors Do Not Prevent the Development and Progression of Urothelial Cancer: In Vitro Evidence
|
Nagata, Yujiro
|
|
|
6 |
4 |
p. 481-488
|
article
|
| 15 |
Synthesis, Characterization, and Biological Activity of Anthraquinone-Substituted Imidazolium Salts for the Treatment of Bladder Cancer
|
Stromyer, Michael L.
|
|
|
6 |
4 |
p. 471-479
|
article
|
| 16 |
Topical Instillations of Chemotherapy for Renal Pelvic Urothelial Cancer
|
Messing, Edward M.
|
|
|
6 |
4 |
p. 557-558
|
article
|
| 17 |
25-Year Trends in Stage-Specific Incidence Rates for Bladder Cancer in a Large Statewide Registry
|
Loloi, Justin
|
|
|
6 |
4 |
p. 445-451
|
article
|
Journal description